Replicel Life Sciences Inc V.RP

Twitter update

[Year3000]

Brief update: we have data pouring in from 3 different programs testing our @DermaPrecise with  all kinds of injectables, materials, and specifications. This is helping us narrow down most ideal applications for market launch and FDA submissions. (1/2)

We are nearly finished  preparations on an Early Adopter Program for Key Opinion Leaders in three continents for pre-clinical and clinical evaluations in  different applications. @DermaPrecise #dermalinjector #dermalinjection More details announced shortly.(2/2)

[MetzGER]

AWESOME NEWS MAN!!!

[Ingiboy]

This is good news for sure.  Finally some sort of an update.  I don't want to be critcal because at this point any update is welcomed but a timeline of when the testing ends and the device is submitted for FDA Approval would have been nice.  The key word in this tweet is FDA not CE Mark. They will focus on launching the device first in the U.S. and then roll it out

[bluemoons20]

Can someone explain  the  information distribution  system  (if one exists)  for  Replicel?? None  of this is noted on their web site  which is where  , at the least,  information  should be centered?? To put stuff out on twitter  and no where else  seems somewhat  sketchy  at the least. What is really happenning other

[Ingiboy]

This was a formal NR which is required when a private placement is announced.  I read it on Stockwatch: https://www.stockwatch.com/News/Item/Z-C!RP-3223905/C/RP